EUVIMEDEUVIMED entdecken
Crossref

In Situ Programming of Armored CAR‐Macrophages by Microneedle‐Mediated Gene Delivery for Melanoma Immunotherapy

Juhyeong Hong iD, Hanseok Lim, Kyungdong Kim, Sangjin Kim, Jaehyun Kim iD, Shayan Fakhraei Lahiji, Yong-Hee Kim iD

Advanced Materials · 18.11.2026

DOI: 10.1002/adma.75787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.11.2026. Verfasst von Juhyeong Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, Hanyang University, Seoul, Republic of Korea. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Ministry of Health and Welfare, Brain Korea 21 Fostering Outstanding Universities for Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite clinical advances in CAR‐T therapy and immune checkpoint blockade, effective immunotherapy for solid tumors remains limited by restricted immune‐cell access and an immunosuppressive tumor microenvironment. Chimeric antigen receptor macrophages (CAR‐M) provide an alternative strategy by combining antigen‐directed myeloid programming with local immune remodeling. A self‐locking microneedle platform incorporating mannose‐modified nanoparticles (MNPs) enables localized in situ programming of CAR‐expressing macrophages at melanoma sites. The platform co‐delivers a tumor‐antigen‐directed CAR and a hypoxia‐responsive anti‐PD‐L1 single‐chain variable fragment (scPD‐L1). Initial studies in B16F10‐OVA tumors establish antigen‐dependent CAR activity and coordinated local immune remodeling. Therapeutic efficacy is subsequently evaluated in parental B16F10 tumors using an endogenous tyrosinase‐related protein 1 (TYRP1)‐directed CAR. MNP(TYRP1/scPD‐L1) microneedles delay tumor progression, prolong survival, and promote coordinated myeloid and CD8 + T‐cell responses, while providing lower terminal tumor burden, greater local surface CAR + tumor‐associated macrophage abundance, and reduced systemic exposure compared with dose‐matched intratumoral administration. Reciprocal depletion further shows that CAR‐programmed macrophages contribute to the antigen‐directed myeloid response, whereas CD8 + T cells are major downstream effectors required for maximal and sustained tumor control. These findings establish a localized transcutaneous strategy that coordinates antigen‐directed myeloid programming with adaptive antitumor immunity.

Schlagwörter

Stichwörter der Autor:innen

CAR macrophageimmune checkpoint blockadein situ gene deliverymelanoma immunotherapyself‐locking microneedletumor‐associated macrophage

Autor:innen und Institutionen

  • Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, Hanyang University, Seoul, Republic of Korea.
  • Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, BK 21 Plus Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seoul, Republic of Korea.
  • Cursus Bio Inc., Seoul Bio Hub, Seoul, Republic of Korea.

ORCID-Profile: Juhyeong Hong, Jaehyun Kim, Yong-Hee Kim

Förderung

  • National Research Foundation of Korea
  • Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Ministry of Health and Welfare
  • Brain Korea 21 Fostering Outstanding Universities for Research

Zitieren

APA

Hong, J., Lim, H., Kim, K., Kim, S., Kim, J., Lahiji, S. F., & Kim, Y. H. (2026). In Situ Programming of Armored CAR‐Macrophages by Microneedle‐Mediated Gene Delivery for Melanoma Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.75787

Vancouver

Hong J, Lim H, Kim K, Kim S, Kim J, Lahiji SF, et al. In Situ Programming of Armored CAR‐Macrophages by Microneedle‐Mediated Gene Delivery for Melanoma Immunotherapy. Advanced Materials. 2026. doi:10.1002/adma.75787

BibTeX
@article{Hong2026,
  author = {Hong, Juhyeong and Lim, Hanseok and Kim, Kyungdong and Kim, Sangjin and Kim, Jaehyun and Lahiji, Shayan Fakhraei and Kim, Yong-Hee},
  title = {In Situ Programming of Armored CAR‐Macrophages by Microneedle‐Mediated Gene Delivery for Melanoma Immunotherapy},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.75787}
}
Kostenlos starten →